Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2016

17.02.2016 | Original Article

Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity

verfasst von: C. Gardiol, R. Voumard, C. Cochet, S. de Vallière

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective and safe alternative to inpatient treatment, but no formal OPAT unit existed in Switzerland until recently. In December 2013 an OPAT unit was established at Lausanne University Hospital. We review here the experience of this new OPAT unit after 18 months of activity. Patient characteristics, clinical activities and outcomes were recorded prospectively. Need and acceptance was evaluated as number of OPAT courses administered and number of patients refusing OPAT. Safety and efficacy were evaluated as: (1) adverse events linked to antimicrobials and catheters, (2) re-admission to hospital, (3) rate of treatment failures and (4) mortality. Over 18 months, 179 courses of OPAT were administered. Acceptance was high with only four patients refusing OPAT. Urinary tract infections with resistant bacteria and musculoskeletal infections were the most common diagnoses. Self-administration of antibiotics using elastomeric pumps became rapidly the most frequently used approach. Sixteen patients presented with adverse events linked to antimicrobials and catheters. OPAT-related readmissions occurred in nine patients. The overall cure rate was 94 %. This study shows that OPAT is very well accepted by patients and medical staff, even in a setting which has not used this type of treatment approach until now. Self-administration using elastomeric pumps proved to be particularly useful, safe and efficient. OPAT offers a good alternative to hospitalisation for patients presenting with infections due to resistant bacteria that cannot be treated orally anymore and for difficult to treat infections.
Literatur
1.
Zurück zum Zitat Rucker RW, Harrison GM (1974) Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 54:358–360PubMed Rucker RW, Harrison GM (1974) Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 54:358–360PubMed
2.
Zurück zum Zitat Barr DA, Semple L, Seaton RA (2012) Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 39:407–413CrossRefPubMed Barr DA, Semple L, Seaton RA (2012) Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 39:407–413CrossRefPubMed
3.
Zurück zum Zitat Seetoh T, Lye DC, Cook AR et al (2013) An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents 41:569–573CrossRefPubMed Seetoh T, Lye DC, Cook AR et al (2013) An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort. Int J Antimicrob Agents 41:569–573CrossRefPubMed
4.
Zurück zum Zitat Subedi S, Looke DFM, McDougall DA et al (2015) Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis 30:161–165CrossRefPubMed Subedi S, Looke DFM, McDougall DA et al (2015) Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis 30:161–165CrossRefPubMed
5.
Zurück zum Zitat Tice AD, Rehm SJ, Dalovisio JR et al (2004) Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA Guide Clin Infect Dis 38:1651–1672CrossRef Tice AD, Rehm SJ, Dalovisio JR et al (2004) Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA Guide Clin Infect Dis 38:1651–1672CrossRef
6.
Zurück zum Zitat Chapman ALN, Seaton RA, Cooper MA et al (2012) Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 67:1053–1062CrossRefPubMed Chapman ALN, Seaton RA, Cooper MA et al (2012) Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 67:1053–1062CrossRefPubMed
7.
Zurück zum Zitat Galpérine T, Ader F, Piriou P et al (2006) Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections. Méd Mal Infect 36:132–137CrossRefPubMed Galpérine T, Ader F, Piriou P et al (2006) Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections. Méd Mal Infect 36:132–137CrossRefPubMed
8.
Zurück zum Zitat Matthews PC, Conlon CP, Berendt AR et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60:356–362CrossRefPubMed Matthews PC, Conlon CP, Berendt AR et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60:356–362CrossRefPubMed
9.
Zurück zum Zitat Howden BP, Richards MJ (2001) The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. J Antimicrob Chemother 48:311–314CrossRefPubMed Howden BP, Richards MJ (2001) The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. J Antimicrob Chemother 48:311–314CrossRefPubMed
10.
Zurück zum Zitat Walton AL, Howden BP, Grayson LM et al (2007) Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens. Int J Antimicrob Agents 29:544–548CrossRefPubMed Walton AL, Howden BP, Grayson LM et al (2007) Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens. Int J Antimicrob Agents 29:544–548CrossRefPubMed
11.
Zurück zum Zitat Prescott WA Jr, Gentile AE, Nagel JL et al (2011) Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis. P T Peer Rev J Form Manag 36:723–763 Prescott WA Jr, Gentile AE, Nagel JL et al (2011) Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis. P T Peer Rev J Form Manag 36:723–763
12.
Zurück zum Zitat Nathwani D, Zambrowski J-J (2000) Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy. Clin Microbiol Infect 6:464–476CrossRefPubMed Nathwani D, Zambrowski J-J (2000) Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy. Clin Microbiol Infect 6:464–476CrossRefPubMed
13.
Zurück zum Zitat Paladino JA, Poretz D (2010) Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 51:S198–S208CrossRefPubMed Paladino JA, Poretz D (2010) Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 51:S198–S208CrossRefPubMed
14.
Zurück zum Zitat Walker SE, Iazzetta J, Law S et al (2010) Stability of commonly used antibiotic solutions in an elastomeric infusion device. Can J Hosp Pharm 63:212–224PubMedPubMedCentral Walker SE, Iazzetta J, Law S et al (2010) Stability of commonly used antibiotic solutions in an elastomeric infusion device. Can J Hosp Pharm 63:212–224PubMedPubMedCentral
15.
Zurück zum Zitat Dellamorte Bing C, Nowobilski-Vasilios A (2015) Extended stability for parenteral drugs. 5th edn. American Society of Health-System Pharmacists Dellamorte Bing C, Nowobilski-Vasilios A (2015) Extended stability for parenteral drugs. 5th edn. American Society of Health-System Pharmacists
16.
Zurück zum Zitat Upton A, Ellis-Pegler R, Woodhouse A (2004) Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital. NZ Med J 117:U1020 Upton A, Ellis-Pegler R, Woodhouse A (2004) Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital. NZ Med J 117:U1020
17.
Zurück zum Zitat Nguyen HH (2010) Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis 51(Suppl 2):S220–S223CrossRefPubMed Nguyen HH (2010) Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis 51(Suppl 2):S220–S223CrossRefPubMed
18.
Zurück zum Zitat Allison GM, Muldoon EG, Kent DM et al (2014) Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis 58:812–819CrossRefPubMedPubMedCentral Allison GM, Muldoon EG, Kent DM et al (2014) Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis 58:812–819CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Meier S, Weber R, Zbinden R et al (2011) Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39:333–340CrossRefPubMed Meier S, Weber R, Zbinden R et al (2011) Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39:333–340CrossRefPubMed
22.
Zurück zum Zitat Chapman ALN, Dixon S, Andrews D et al (2009) Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 64:1316–1324CrossRefPubMed Chapman ALN, Dixon S, Andrews D et al (2009) Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 64:1316–1324CrossRefPubMed
23.
Zurück zum Zitat Pajarón M, Fernández-Miera MF, Allende I et al (2015) Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: A safe and effective model. Eur J Int Med 26:131–136CrossRef Pajarón M, Fernández-Miera MF, Allende I et al (2015) Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: A safe and effective model. Eur J Int Med 26:131–136CrossRef
24.
Zurück zum Zitat Viaene E, Chanteux H, Servais H et al (2002) Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrob Agents Chemother 46:2327–2332CrossRefPubMedPubMedCentral Viaene E, Chanteux H, Servais H et al (2002) Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrob Agents Chemother 46:2327–2332CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Arlicot N, Rochefort GY, Schlecht D et al (2007) Stability of antibiotics in portable pumps used for bronchial superinfection: guidelines for prescribers. Pediatrics 120:1255–1259CrossRefPubMed Arlicot N, Rochefort GY, Schlecht D et al (2007) Stability of antibiotics in portable pumps used for bronchial superinfection: guidelines for prescribers. Pediatrics 120:1255–1259CrossRefPubMed
26.
Zurück zum Zitat Zeller V, Durand F, Kitzis M-D et al (2009) Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations. Antimicrob Agents Chemother 53:883–887CrossRefPubMedPubMedCentral Zeller V, Durand F, Kitzis M-D et al (2009) Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations. Antimicrob Agents Chemother 53:883–887CrossRefPubMedPubMedCentral
Metadaten
Titel
Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity
verfasst von
C. Gardiol
R. Voumard
C. Cochet
S. de Vallière
Publikationsdatum
17.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2016
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2606-z

Weitere Artikel der Ausgabe 5/2016

European Journal of Clinical Microbiology & Infectious Diseases 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.